J Nerv Ment Dis. 2020 Jan;208(1):70-76
Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN-BIND-1 report.
Int J Neuropsychopharmacol. 2019 Dec 10;:
Reliability of a functional magnetic resonance imaging task of emotional conflict in healthy participants.
Hum Brain Mapp. 2019 Dec 03;:
Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study.
J Affect Disord. 2019 Nov 13;:
Collaborating with individuals with lived experience to adapt CANMAT clinical depression guidelines into a patient treatment guide: The CHOICE-D co-design process.
J Eval Clin Pract. 2019 Nov 14;:
Early Interv Psychiatry. 2019 Nov 13;:
Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
Brain Stimul. 2019 Oct 31;:
Microb Cell. 2019 Sep 27;6(10):454-481
Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
JAMA Netw Open. 2019 Oct 02;2(10):e1913304
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.
Neuropsychopharmacology. 2019 Oct 14;: